Shattuck Labs (STTK) Interest & Investment Income (2019 - 2026)

Shattuck Labs (STTK) posted quarterly Interest & Investment Income of $779000.0 for Q1 2026, up 13.06% year-over-year from $689000.0 in Q1 2025, and up 13.06% quarter-over-quarter from $689000.0 in Q1 2025.

Shattuck Labs (STTK) Interest & Investment Income (2019 - 2026) Analysis & Trends

Shattuck Labs (STTK) has reported Interest & Investment Income for 5 consecutive years, with $779000.0 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Interest & Investment Income rose 13.06% year-over-year to $779000.0; the TTM figure through Mar 2026 stood at $397000.0 (down 35.76% YoY), while the FY2025 annual figure was $2.7 million, down 47.76% from the prior year.
  • Interest & Investment Income advanced to $779000.0 in Q1 2026 per STTK's latest filing, from $689000.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $779000.0 in Q1 2026 and bottomed at $689000.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 120.60 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -48.00 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 48.00 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 35.58 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 27.90 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - 5.13 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 28.14 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 10.98 Mn
10 Shattuck Labs 962.96 Mn 962.96 Mn - 1.03 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 1.03 Mn
Mar 31, 2026 779,000.00
Mar 31, 2025 689,000.00
Dec 31, 2021 -1.32 Mn
Sep 30, 2021 251,000.00
Jun 30, 2021 1.00 Mn
Mar 31, 2021 696,000.00
Dec 31, 2020 75,000.00
Sep 30, 2020 86,000.00
Jun 30, 2020 138,000.00
Mar 31, 2020 250,000.00
Dec 31, 2019 282,000.00
Sep 30, 2019 279,000.00